Harvard Bioscience Inc (HBIO): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2026-05-12. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

44.39M
Year ended 2025-12-31
+2.3%
3-year compound annual growth
+2.8%
5-year compound annual growth
+2.8%
10-year compound annual growth
2009-12-31: 29.95M2010-12-31: 29.40M2011-12-31: 29.82M2012-12-31: 29.79M2013-12-31: 31.91M2014-12-31: 33.24M2015-12-31: 33.59M2016-12-31: 34.21M2017-12-31: 34.75M2018-12-31: 36.45M2019-12-31: 37.81M2020-12-31: 38.64M2021-12-31: 40.34M2022-12-31: 41.41M2023-12-31: 42.42M2024-12-31: 43.54M2025-12-31: 44.39M44.39M
2009-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3144.39M+2.0%2026-03-13, From 2025-01-01
2024-12-3143.54M+2.6%2026-03-13, From 2024-01-01
2023-12-3142.42M+2.4%2025-03-14, From 2023-01-01
2022-12-3141.41M+2.7%2024-03-07, From 2022-01-01
2021-12-3140.34M+4.4%2023-03-09, From 2021-01-01
2020-12-3138.64M+2.2%2022-03-11, From 2020-01-01
2019-12-3137.81M+3.7%2021-03-17, From 2019-01-01
2018-12-3136.45M+4.9%2020-03-16, From 2018-01-01
2017-12-3134.75M+1.6%2019-03-18, From 2017-01-01
2016-12-3134.21M+1.8%2018-03-16, From 2016-01-01
2015-12-3133.59M+1.1%2018-03-16, From 2015-01-01
2014-12-3133.24M+4.1%2017-03-17, From 2014-01-01
2013-12-3131.91M+7.1%2016-04-29, From 2013-01-01
2012-12-3129.79M-0.1%2015-03-12, From 2012-01-01
2011-12-3129.82M+1.4%2014-03-14, From 2011-01-01
2010-12-3129.40M-1.8%2013-03-18, From 2010-01-01
2009-12-3129.95Mn/a2012-03-15, From 2009-01-01